Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number ADA574943
Title Medical Countermeasure Models. Volume 8. Botulinum Neurotoxin.
Publication Date Apr 2013
Media Count 68p
Personal Author J. Corbin L. Sumner R. Casagrande
Abstract The botulinum neurotoxin medical countermeasure model presented here allows users to explore how medical countermeasures (MCM) can impact the course of the disease, mortality, and loss of work. The model is designed to allow users to input information about exposure and countermeasures, run a simulation and display outputs. The parameters describing disease outcomes for untreated patients that underlie the model are taken from AMedP-8(C), while the parameters describing the efficacy of MCM were established specifically for this project using publicly available data from human and animal studies. This stochastic model allows users to input data about each exposed individual including the inhaled dose, pre-exposure vaccine status, and treatment status and timing. After the model is run, the output tab displays the outcome for each individual. The graph tab provides a summary of the results, including the percent of individuals that die, recover, or never develop illness, as well as the time distributions of symptom onset and death. The sample results included in this report demonstrate how MCM can impact the number of casualties, the timing of the disease, and the number of days of work lost. Users of the model can explore additional scenarios by modifying the dose and MCM inputs.
Keywords Bacterial toxins
Clostridium botulinum
Display systems
Mcm(Medical countermeasure)
Medical services
Mortality rate
Stochastic processes
Work lost casualties

Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
57K - Microbiology
Corporate Author Defense Threat Reduction Agency, Fort Belvoir, VA. Chemical and Biological Defense.
Document Type Technical report
Title Note Final rept. 15 Apr 2010-12 Apr 2013.
NTIS Issue Number 1319
Contract Number HDTRA1-10-C-0025

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader